title: What is the clinical impact of the LUX-Lung 5 trial?
authors.affiliation: Department of Oncology, Bristol Cancer Centre, Bristol, UK. Electronic address: alfredo.addeo@uhbristol.nhs.uk.
authors.forename: A
authors.initials: A
authors.lastname: Addeo
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung; D006801:Humans; D008175:Lung Neoplasms; D011799:Quinazolines
chemical_list: D011799:Quinazolines